{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:05:46Z","timestamp":1792098346320,"version":"4.4.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ejim.2014.08.008","type":"journal-article","created":{"date-parts":[[2014,9,27]],"date-time":"2014-09-27T17:48:03Z","timestamp":1411840083000},"page":"689-694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":389,"title":["Current knowledge of hypertriglyceridemic pancreatitis"],"prefix":"10.1016","volume":"25","author":[{"given":"Pedro","family":"Valdivielso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Ram\u00edrez-Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Ewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2014.08.008_bb0005","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1477-2574.2009.00072.x","article-title":"National hospital volume in acute pancreatitis: analysis of the Nationwide Inpatient Sample 1998\u20132006","volume":"11","author":"Singla","year":"2009","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.ejim.2014.08.008_bb0010","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1056\/NEJMcp054958","article-title":"Clinical practice. Acute pancreatitis","volume":"354","author":"Whitcomb","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2014.08.008_bb0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/01.mpa.0000236733.31617.52","article-title":"Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review","volume":"33","author":"Yadav","year":"2006","journal-title":"Pancreas"},{"key":"10.1016\/j.ejim.2014.08.008_bb0020","first-page":"1806","article-title":"Underrecognition of chylomicronemia as a cause of acute pancreatitis","volume":"147","author":"Searles","year":"1992","journal-title":"CMAJ"},{"key":"10.1016\/j.ejim.2014.08.008_bb0025","first-page":"2134","article-title":"Clinical assessment of hyperlipidemic pancreatitis","volume":"90","author":"Fortson","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2014.08.008_bb0030","first-page":"82","article-title":"The early management of pancreatitis associated with hypertriglyceridaemia","volume":"49","author":"Anderson","year":"2011","journal-title":"S Afr J Surg"},{"key":"10.1016\/j.ejim.2014.08.008_bb0035","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S1499-3872(11)60131-8","article-title":"Triglyceride levels and apolipoprotein E polymorphism in patients with acute pancreatitis","volume":"11","author":"Ivanova","year":"2012","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.ejim.2014.08.008_bb0040","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/gut.33.7.982","article-title":"Relation of diagnostic serum amylase levels to aetiology and severity of acute pancreatitis","volume":"33","author":"Winslet","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2014.08.008_bb0045","first-page":"1602","article-title":"Hypertriglyceridemia-induced pancreatitis","volume":"71","author":"Nagayama","year":"2013","journal-title":"Nihon Rinsho"},{"key":"10.1016\/j.ejim.2014.08.008_bb0050","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00004836-200204000-00020","article-title":"Long-term follow-up of patients with acute hypertriglyceridemia-induced pancreatitis","volume":"34","author":"Athyros","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ejim.2014.08.008_bb0055","first-page":"85","article-title":"Acute pancreatitis in pregnancy","volume":"61","author":"Chang","year":"1998","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.ejim.2014.08.008_bb0060","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jacl.2012.06.005","article-title":"The interaction of familial and secondary causes of hypertriglyceridemia: role in pancreatitis","volume":"6","author":"Brunzell","year":"2012","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ejim.2014.08.008_bb0065","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0025-7125(16)31430-4","article-title":"Chylomicronemia syndrome. Interaction of genetic and acquired hypertriglyceridemia","volume":"66","author":"Brunzell","year":"1982","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.ejim.2014.08.008_bb0070","first-page":"249","article-title":"Chylomicronemia syndrome","volume":"37","author":"Chait","year":"1992","journal-title":"Adv Intern Med"},{"key":"10.1016\/j.ejim.2014.08.008_bb0075","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0889-8529(05)70025-6","article-title":"The familial chylomicronemia syndrome","volume":"27","author":"Santamarina-Fojo","year":"1998","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ejim.2014.08.008_bb0080","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2796.2011.02361.x","article-title":"Childhood-onset chylomicronaemia with reduced plasma lipoprotein lipase activity and mass: identification of a novel GPIHBP1 mutation","volume":"270","author":"Coca-Prieto","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/j.ejim.2014.08.008_bb0085","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-230X-9-46","article-title":"Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitis","volume":"9","author":"Coca-Prieto","year":"2009","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ejim.2014.08.008_bb0090","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1476-511X-10-157","article-title":"Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study","author":"Sandhu","year":"2011","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.ejim.2014.08.008_bb0095","doi-asserted-by":"crossref","first-page":"13-2","DOI":"10.1097\/MPA.0b013e31816074a1","article-title":"Acute pancreatitis in a cohort of 129 patients referred for severe hypertriglyceridemia","volume":"37","author":"Linares","year":"2008","journal-title":"Pancreas"},{"key":"10.1016\/j.ejim.2014.08.008_bb0100","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1567-5688(03)91006-3","article-title":"3P-0788 Severe chylomicronemia: clinical epidemiology and recommendations for treatment","volume":"4","author":"Kloer","year":"2003","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.ejim.2014.08.008_bb0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.arteri.2012.11.001","article-title":"Perfil cl\u00ednico de los pacientes con hipertrigliceridemia muy severa del Registro de Hipertrigliceridemias de la Sociedad Espa\u00f1ola de Arteriosclerosis","volume":"25","author":"Pedragosa","year":"2013","journal-title":"Clin Investig Arterioscler"},{"key":"10.1016\/j.ejim.2014.08.008_bb0110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/2013.jamainternmed.477","article-title":"Hypertriglyceridemia and acute pancreatitis","volume":"173","author":"Murphy","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ejim.2014.08.008_bb0115","first-page":"117","article-title":"Pathogenesis, differentiation and management of hypertriglyceridemia","volume":"15","author":"Havel","year":"1969","journal-title":"Adv Intern Med"},{"key":"10.1016\/j.ejim.2014.08.008_bb0120","first-page":"60","article-title":"Acute pancreatitis with hyperlipemia: studies with an isolated perfused canine pancreas","volume":"82","author":"Saharia","year":"1977","journal-title":"Surgery"},{"key":"10.1016\/j.ejim.2014.08.008_bb0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF02803766","article-title":"Role of hypertriglyceridemia in the pathogenesis of experimental acute pancreatitis in rats","volume":"20","author":"Kimura","year":"1996","journal-title":"Int J Pancreatol"},{"key":"10.1016\/j.ejim.2014.08.008_bb0130","first-page":"2318","article-title":"Hypertriglyceridemia aggravates ER stress and pathogenesis of acute pancreatitis","volume":"59","author":"Zeng","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.ejim.2014.08.008_bb0135","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1373\/clinchem.2007.093492","article-title":"Association of cystic fibrosis transmembrane conductance regulator (CFTR) mutation\/variant\/haplotype and tumor necrosis factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis","volume":"54","author":"Chang","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.ejim.2014.08.008_bb0140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00534-005-1047-3","article-title":"JPN Guidelines for the management of acute pancreatitis: epidemiology, etiology, natural history, and outcome predictors in acute pancreatitis","volume":"13","author":"Sekimoto","year":"2006","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.ejim.2014.08.008_bb0145","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2217\/clp.12.69","article-title":"Hypertriglyceridemia causes more severe course of acute pancreatitis","volume":"7","author":"Baranyai","year":"2012","journal-title":"Clin Lipidol"},{"key":"10.1016\/j.ejim.2014.08.008_bb0150","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/gut.38.5.753","article-title":"Hyperlipaemia intensifies the course of acute oedematous and acute necrotising pancreatitis in the rat","volume":"38","author":"Hofbauer","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2014.08.008_bb0155","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejphar.2007.05.064","article-title":"Hyperlipidemia induced by a cholesterol-rich diet aggravates necrotizing pancreatitis in rats","volume":"572","author":"Czako","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ejim.2014.08.008_bb0160","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.3748\/wjg.v12.i18.2908","article-title":"Hyperlipidemia intensifies cerulein-induced acute pancreatitis associated with activation of protein kinase C in rats","volume":"12","author":"Wang","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2014.08.008_bb0165","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00000658-197510000-00016","article-title":"The pathogenesis of pulmonary edema in acute pancreatitis","volume":"182","author":"Warshaw","year":"1975","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejim.2014.08.008_bb0170","first-page":"509","article-title":"Respiratory failure in acute pancreatitis: a possible role for triglycerides","volume":"189","author":"Kimura","year":"1979","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejim.2014.08.008_bb0175","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1742-1241.2005.00645.x","article-title":"Hyperlipidaemia and outcome in acute pancreatitis","volume":"60","author":"Balachandra","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ejim.2014.08.008_bb0180","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF02785883","article-title":"Hyperlipidemia in acute pancreatitis. Cause or epiphenomenon?","volume":"18","author":"Dominguez-Munoz","year":"1995","journal-title":"Int J Pancreatol"},{"key":"10.1016\/j.ejim.2014.08.008_bb0185","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.3748\/wjg.14.4558","article-title":"Effect of admission hypertriglyceridemia on the episodes of severe acute pancreatitis","volume":"14","author":"Deng","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2014.08.008_bb0190","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF02924164","article-title":"Hyperlipidemia in acute pancreatitis. Relationship with etiology, onset, and severity of the disease","volume":"10","author":"Dominguez-Munoz","year":"1991","journal-title":"Int J Pancreatol"},{"key":"10.1016\/j.ejim.2014.08.008_bb0195","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: a severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ejim.2014.08.008_bb0200","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00004836-200303000-00013","article-title":"Balthazar computed tomography severity index is superior to Ranson criteria and APACHE II and III scoring systems in predicting acute pancreatitis outcome","volume":"36","author":"Chatzicostas","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ejim.2014.08.008_bb0205","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1148\/radiology.174.2.2296641","article-title":"Acute pancreatitis: value of CT in establishing prognosis","volume":"174","author":"Balthazar","year":"1990","journal-title":"Radiology"},{"key":"10.1016\/j.ejim.2014.08.008_bb0210","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s10620-005-9006-z","article-title":"Heparin and insulin in the treatment of hypertriglyceridemia-induced severe acute pancreatitis","volume":"51","author":"Alag\u00f6zl\u00fc","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ejim.2014.08.008_bb0215","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4166\/kjg.2010.55.6.399","article-title":"Hypertriglyceridemia-induced pancreatitis treated with insulin in a nondiabetic patient","volume":"55","author":"Park","year":"2010","journal-title":"Korean J Gastroenterol"},{"key":"10.1016\/j.ejim.2014.08.008_bb0220","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2146\/ajhp110144","article-title":"Hypertriglyceridemia-induced acute pancreatitis treated with insulin and heparin","volume":"69","author":"Twilla","year":"2012","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ejim.2014.08.008_bb0225","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-008550","article-title":"Acute pancreatitis owing to very high triglyceride levels treated with insulin and heparin infusion","volume":"2013","author":"Aryal","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ejim.2014.08.008_bb0230","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.3748\/wjg.v13.i18.2642","article-title":"Insulin and heparin in treatment of hypertriglyceridemia-induced pancreatitis","volume":"13","author":"Jain","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2014.08.008_bb0235","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1100\/tsw.2009.142","article-title":"Heparin and insulin for hypertriglyceridemia-induced pancreatitis: case report","volume":"9","author":"Jain","year":"2009","journal-title":"Sci World J"},{"key":"10.1016\/j.ejim.2014.08.008_bb0240","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archinternmed.2009.221","article-title":"Heparin treatment for severe hypertriglyceridemia in diabetic ketoacidosis","volume":"169","author":"Cole","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2014.08.008_bb0245","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.4067\/S0034-98872001001200002","article-title":"Heparin and insulin treatment of acute pancreatitis caused by hypertriglyceridemia. Experience of 5 cases","volume":"129","author":"Berger","year":"2001","journal-title":"Rev Med Chil"},{"key":"10.1016\/j.ejim.2014.08.008_bb0250","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1161\/01.ATV.15.8.1086","article-title":"Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins","volume":"15","author":"Tornvall","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejim.2014.08.008_bb0255","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/S0022-2275(20)36948-0","article-title":"Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins","volume":"34","author":"Vilella","year":"1993","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ejim.2014.08.008_bb0260","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1001\/archinternmed.2009.461","article-title":"Concerns about heparin therapy for hypertriglyceridemia","author":"Whayne","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2014.08.008_bb0265","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1067\/mlc.2001.117666","article-title":"Lipoprotein lipase during continuous heparin infusion: tissue stores become partially depleted","volume":"138","author":"Nasstrom","year":"2001","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.ejim.2014.08.008_bb0270","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0022-2143(03)00059-3","article-title":"Lower plasma levels of lipoprotein lipase after infusion of low molecular weight heparin than after administration of conventional heparin indicate more rapid catabolism of the enzyme","volume":"142","author":"Nasstrom","year":"2003","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.ejim.2014.08.008_bb0275","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/pgmj.67.794.1062","article-title":"Lipoprotein lipase deficiency due to long-term heparinization presenting as severe hypertriglyceridaemia in pregnancy","volume":"67","author":"Watts","year":"1991","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ejim.2014.08.008_bb0280","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3346\/jkms.2010.25.9.1375","article-title":"Severe hypertriglyceridemia in diabetic ketoacidosis accompanied by acute pancreatitis: case report","volume":"25","author":"Hahn","year":"2010","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.ejim.2014.08.008_bb0285","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.09.2011.4819","article-title":"\u2018A lipaemic mystery\u2019: a patient with hypertriglyceridaemic pancreatitis and cerebral infarction","volume":"2011","author":"King","year":"2011","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ejim.2014.08.008_bb0290","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-202039","article-title":"Fatal hypertriglyceridaemia, acute pancreatitis and diabetic ketoacidosis possibly induced by quetiapine","volume":"2014","author":"Madsen","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ejim.2014.08.008_bb0295","first-page":"77","article-title":"Severe hypertriglyceridemia causing acute pancreatitis in a child with new onset type I diabetes mellitus presenting in ketoacidosis","volume":"2","author":"Wolfgram","year":"2013","journal-title":"J Pediatr Intensive Care"},{"key":"10.1016\/j.ejim.2014.08.008_bb0300","first-page":"235","article-title":"Insulin therapy in patients with severe hypertriglyceridemia","volume":"44","author":"Tamez-Perez","year":"2006","journal-title":"Rev Med Inst Mex Seguro Soc"},{"key":"10.1016\/j.ejim.2014.08.008_bb0305","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1464-5491.2010.03036.x","article-title":"Safe and rapid resolution of severe hypertriglyceridaemia in two patients with intravenous insulin","volume":"27","author":"Triay","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/j.ejim.2014.08.008_bb0310","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/qjmed\/hcs238","article-title":"Severe hypertriglyceridaemia in Type 2 diabetes mellitus: beneficial effect of continuous insulin infusion","volume":"106","author":"Henderson","year":"2013","journal-title":"QJM"},{"key":"10.1016\/j.ejim.2014.08.008_bb0315","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejim.2013.08.701","article-title":"Plasmapheresis as treatment for hyperlipidemic pancreatitis","volume":"25","author":"Ramirez-Bueno","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2014.08.008_bb0320","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.3748\/wjg.v10.i15.2272","article-title":"Therapeutic plasma exchange in patients with hyperlipidemic pancreatitis","volume":"10","author":"Chen","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2014.08.008_bb0325","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jca.10063","article-title":"Plasmapheresis for hyperlipidemic pancreatitis","volume":"18","author":"Yeh","year":"2003","journal-title":"J Clin Apher"},{"key":"10.1016\/j.ejim.2014.08.008_bb0330","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1744-9987.2009.00731.x","article-title":"Treatment of hyperlipidemic acute pancreatitis with plasma exchange: a single-center experience","author":"Gubensek","year":"2009","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.ejim.2014.08.008_bb0335","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1744-9987.2008.00572.x","article-title":"Therapeutic plasma exchange for acute hyperlipidemic pancreatitis: a case series","volume":"12","author":"Al-Humoud","year":"2008","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.ejim.2014.08.008_bb0340","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000095425","article-title":"Management of acute severe hyperlipidemic pancreatitis","volume":"73","author":"Kyriakidis","year":"2006","journal-title":"Digestion"},{"key":"10.1016\/j.ejim.2014.08.008_bb0345","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.transci.2005.11.009","article-title":"Plasma exchange in severe hypertriglyceridemia a clinical study","volume":"34","author":"Kadikoylu","year":"2006","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.ejim.2014.08.008_bb0350","doi-asserted-by":"crossref","first-page":"e102748","DOI":"10.1371\/journal.pone.0102748","article-title":"Factors affecting outcome in hypertriglyceridemic pancreatitis treated with plasma exchange","volume":"9","author":"Gubensek","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2014.08.008_bb0355","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.transci.2010.09.009","article-title":"Emergent therapy with therapeutic plasma exchange in acute recurrent pancreatitis due to severe hypertriglyceridemia","volume":"43","author":"Kadikoylu","year":"2010","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.ejim.2014.08.008_bb0360","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jca.21276","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue","volume":"28","author":"Schwartz","year":"2013","journal-title":"J Clin Apher"},{"key":"10.1016\/j.ejim.2014.08.008_bb0365","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF02788396","article-title":"Prevention of hyperlipidemic acute pancreatitis during pregnancy with medium-chain triglyceride nutritional support","volume":"23","author":"Mizushima","year":"1998","journal-title":"Int J Pancreatol"},{"key":"10.1016\/j.ejim.2014.08.008_bb0370","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000283561","article-title":"Successful treatment of severe hypertriglyceridemia with a formula diet rich in omega-3 fatty acids and medium-chain triglycerides","volume":"56","author":"Hauenschild","year":"2010","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.ejim.2014.08.008_bb0375","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000138126","article-title":"Successful long-term treatment of severe hypertriglyceridemia by feedback control with lipid self-monitoring","volume":"52","author":"Hauenschild","year":"2008","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.ejim.2014.08.008_bb0380","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jacl.2012.11.006","article-title":"Lipoprotein abnormalities in compound heterozygous lipoprotein lipase deficiency after treatment with a low-fat diet and orlistat","volume":"7","author":"Blackett","year":"2013","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ejim.2014.08.008_bb0385","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(12)61731-0","article-title":"Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study","volume":"381","author":"Cuchel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2014.08.008_bb0390","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/jamainternmed.2013.13309","article-title":"Severe hypertriglyceridemia with pancreatitis: thirteen years' treatment with lomitapide","volume":"174","author":"Sacks","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ejim.2014.08.008_bb0395","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/gt.2012.43","article-title":"Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial","volume":"20","author":"Gaudet","year":"2013","journal-title":"Gene Ther"},{"key":"10.1016\/j.ejim.2014.08.008_bb0400","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00006676-199607000-00013","article-title":"Prevention of recurrent acute pancreatitis in patients with severe hypertriglyceridemia: value of regular plasmapheresis","volume":"13","author":"Piolot","year":"1996","journal-title":"Pancreas"},{"key":"10.1016\/j.ejim.2014.08.008_bb0405","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1525-1594.2009.00810.x","article-title":"Therapeutic plasma exchange in patients with severe hypertriglyceridemia: a multicenter study","volume":"33","author":"Stefanutti","year":"2009","journal-title":"Artif Organs"},{"key":"10.1016\/j.ejim.2014.08.008_bb0410","first-page":"646","article-title":"Diet and hypertriglyceridemia: influence of dietary modifications on plasma lipids, lipoproteins and apoproteins in patients with primary hypertriglyceridemia","volume":"98","author":"Soriguer Escofet","year":"1992","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.ejim.2014.08.008_bb0415","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jacl.2012.04.003","article-title":"Treatment options for the management of hypertriglyceridemia: strategies based on the best-available evidence","volume":"6","author":"Maki","year":"2012","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ejim.2014.08.008_bb0420","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1476-511X-11-143","article-title":"Titrating lovaza from 4 to 8 to 12grams\/day in patients with primary hypertriglyceridemia who had triglyceride levels >500mg\/dl despite conventional triglyceride lowering therapy","volume":"11","author":"Glueck","year":"2012","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.ejim.2014.08.008_bb0425","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jacl.2013.10.003","article-title":"Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial","volume":"8","author":"Kastelein","year":"2014","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ejim.2014.08.008_bb0430","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/ajcn\/51.3.399","article-title":"Fish oils in hypertriglyceridemia: a dose\u2013response study","volume":"51","author":"Harris","year":"1990","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ejim.2014.08.008_bb0435","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/jama.2012.8439","article-title":"Lipid-modifying therapies and risk of pancreatitis: a meta-analysis","author":"Preiss","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2014.08.008_bb0440","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1586\/egh.12.79","article-title":"Triglyceride levels, pancreatitis and choice of lipid-modifying therapy","volume":"7","author":"Preiss","year":"2013","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2014.08.008_bb0445","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1210\/jc.2011-3213","article-title":"Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline","volume":"97","author":"Berglund","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2014.08.008_bb0450","doi-asserted-by":"crossref","first-page":"662","DOI":"10.7326\/0003-4819-157-9-201211060-00011","article-title":"Drug treatment of asymptomatic hypertriglyceridemia to prevent pancreatitis: where is the evidence?","volume":"157","author":"Lederle","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2014.08.008_bb0455","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.amjmed.2013.09.018","article-title":"Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia","volume":"127","author":"Christian","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2014.08.008_bb0460","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/ajg.2009.27","article-title":"Hypertriglyceridemic pancreatitis: presentation and management","volume":"104","author":"Tsuang","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2014.08.008_bb0465","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/MOL.0b013e3283319a1d","article-title":"Severe hypertriglyceridemia and pancreatitis: presentation and management","volume":"20","author":"Ewald","year":"2009","journal-title":"Curr Opin Lipidol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362051400243X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362051400243X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T23:49:05Z","timestamp":1650239345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095362051400243X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":93,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S095362051400243X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2014.08.008","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current knowledge of hypertriglyceridemic pancreatitis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2014.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}